To date, the firm has analyzed more than 2,000 health tech companies in pre-seed, seed, and Series A stages. “This second fund is a natural …
To date, the firm has analyzed more than 2,000 health tech companies in pre-seed, seed, and Series A stages. “This second fund is a natural …